Winning team to receive a cash prize of ₹2 lakh. Global online competition culminates in an onsite Grand Finale at the UST campus in Thiruvananthapuram, India.  THIRUVANANTHAPURAM, India, Aug. 13, 2026 /PRNewswire/ — UST, a leading AI and technology transformation solutions company, has opened registrations for the GenCyS 2.0 Global Capture-The-Flag (CTF) competition, the flagship event of its GenCyS 2.0 AI & Cybersecurity Conference. […]

This announcement contains inside information for the purposes of Article 7 of the UK version of Regulation (EU) No 596/2014 which is part of UK law by virtue of the European Union (Withdrawal) Act 2018, as amended. Upon the publication of this announcement via a Regulatory Information Service, this inside information is now considered to

PARIS, Aug. 13, 2026 /PRNewswire/ — Thierry EHRMANN, Founder of Artprice and CEO of Artmarket.com, and his family have full confidence in the future of Artmarket.com and in the growth of its activities, driven notably by substantial investments dedicated to the development of Artmarket.com’s vertical AI. The expression of support from the Ehrmann family and

SHANGHAI, Aug. 13, 2026 /PRNewswire/ — Angelalign Technology Inc. (6699.HK) (“Angel”) http://www.angelaligner.com said today that it will appeal the August 10 first-instance judgment by the Jinan Intermediate People’s Court (Jinan City, China) that directed Angel’s Chinese subsidiaries to stop using the masterForce biomechanics simulation system and the ATreat digital diagnosis and design system to generate A7

SHANGHAI, Aug. 13, 2026 /PRNewswire/ — Shanghai Ark Biopharmaceutical Co., Ltd. (“ArkBio”) today announced that the Investigational New Drug (IND) application for AK0406 injection, the company’s first long-acting antiviral drug‑Fc conjugate (AFC) candidate for influenza prophylaxis, has been approved by the National Medical Products Administration (NMPA) of China, making AK0406 the first influenza AFC drug